CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Feb 12, 16:00
CureVac Cash from Investing (Quarterly) : -0.447M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioNTech SE | -994.84M |
| Immatics NV | 147.12M |
| Bayer AG | -1.314B |
| MediGene AG | -- |
| InflaRx NV | 2.795M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 32.04M |
| Cash from Financing (Quarterly) | -1.596M |
| Free Cash Flow | -144.00M |
| Free Cash Flow Per Share (Quarterly) | 0.1399 |
| Free Cash Flow to Equity (Quarterly) | 32.68M |
| Free Cash Flow to Firm (Quarterly) | 37.74M |
| Free Cash Flow Yield | -13.73% |